- Home
- Publications
- Publication Search
- Publication Details
Title
Tryptophan Metabolism as a Pharmacological Target
Authors
Keywords
tryptophan, kynurenine, serotonin, IDO, AhR, therapeutics
Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 42, Issue 1, Pages 60-73
Publisher
Elsevier BV
Online
2020-11-27
DOI
10.1016/j.tips.2020.11.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Immunomodulator 1-Methyltryptophan Drives Tryptophan Catabolism Toward the Kynurenic Acid Branch
- (2020) Elisa Wirthgen et al. Frontiers in Immunology
- Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells
- (2020) Elizabeth C. Rosser et al. Cell Metabolism
- A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression
- (2020) Lawrence T Park et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma
- (2020) David A. Reardon et al. INVESTIGATIONAL NEW DRUGS
- Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity
- (2020) Marta Serafini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Possibility of Amino Acid Treatment to Prevent the Psychiatric Disorders via Modulation of the Production of Tryptophan Metabolite Kynurenic Acid
- (2020) Tsutomu Fukuwatari Nutrients
- Kynurenic Acid Levels are Increased in the CSF of Alzheimer’s Disease Patients
- (2020) Marta González-Sánchez et al. Biomolecules
- Discovery of indoximod prodrugs and characterization of clinical candidate NLG802
- (2020) Sanjeev Kumar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pyridoxal 5′-Phosphate-Dependent Enzymes at the Crossroads of Host–Microbe Tryptophan Metabolism
- (2020) Barbara Cellini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression
- (2020) Ahmed Sadik et al. CELL
- Indole-3-Propionic Acid, a Tryptophan-Derived Bacterial Metabolite, Reduces Weight Gain in Rats
- (2019) Piotr Konopelski et al. Nutrients
- Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
- (2019) Michael Platten et al. NATURE REVIEWS DRUG DISCOVERY
- Next generation probiotics in disease amelioration
- (2019) Chih-Jung Chang et al. JOURNAL OF FOOD AND DRUG ANALYSIS
- BMS-986205, an indoleamine 2, 3-dioxygenase 1 inhibitor (IDO1i), in combination with nivolumab (nivo): Updated safety across all tumor cohorts and efficacy in advanced bladder cancer (advBC).
- (2019) Jason J. Luke et al. JOURNAL OF CLINICAL ONCOLOGY
- Skatole regulates intestinal epithelial cellular functions through activating aryl hydrocarbon receptors and p38
- (2019) Koichi Kurata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Opposite Effect of L-kynurenine and Ahr Inhibitor Ch223191 on Apoptotic Protein Expression in Pancreatic Carcinoma Cells (Panc-1)
- (2019) Anna Leja-Szpak et al. Anti-Cancer Agents in Medicinal Chemistry
- High phthalate exposure increased urinary concentrations of quinolinic acid, implicated in the pathogenesis of neurological disorders: Is this a potential missing link?
- (2019) Feiby L. Nassan et al. ENVIRONMENTAL RESEARCH
- Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
- (2019) Jochen Kindler et al. MOLECULAR PSYCHIATRY
- Emerging Health Concepts in the Probiotics Field: Streamlining the Definitions
- (2019) Rebeca Martín et al. Frontiers in Microbiology
- A novel role of kynureninase in the growth control of breast cancer cells and its relationships with breast cancer
- (2019) Yingzhe Liu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Selective and competitive inhibition of kynurenine aminotransferase 2 by glycyrrhizic acid and its analogues
- (2019) Yukihiro Yoshida et al. Scientific Reports
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- Role of Nicotinamide in Genomic Stability and Skin Cancer Chemoprevention
- (2019) Luca Fania et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Does kynurenic acid act on nicotinic receptors? An assessment of the evidence
- (2019) Trevor W. Stone JOURNAL OF NEUROCHEMISTRY
- Laquinimod Supports Remyelination in Non-Supportive Environments
- (2019) Stella Nyamoya et al. Cells
- Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs)
- (2019) Daniela Dolciami et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tumor-Repopulating Cells Induce PD-1 Expression in CD8 + T Cells by Transferring Kynurenine and AhR Activation
- (2018) Yuying Liu et al. CANCER CELL
- Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
- (2018) Allison Agus et al. Cell Host & Microbe
- Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion
- (2018) Yogesh Bhattarai et al. Cell Host & Microbe
- Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation
- (2018) Leandro Z. Agudelo et al. Cell Metabolism
- α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis
- (2018) Roberto Pellicciari et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Safety and Tolerability of Topically Delivered Kynurenic Acid in Humans. A Phase 1 Randomized Double-Blind Clinical Trial
- (2018) Anthony Papp et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A Phase 2, Randomized Dose-Finding Study of Tapinarof (GSK2894512 Cream) for the Treatment of Atopic Dermatitis
- (2018) Johnny Peppers et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease
- (2018) Kuo-Hsuan Chang et al. MOLECULAR NEUROBIOLOGY
- Aryl hydrocarbon receptor and intestinal immunity
- (2018) Bruno Lamas et al. Mucosal Immunology
- Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health
- (2018) Ludivine Laurans et al. NATURE MEDICINE
- Beneficial actions of microbiota-derived tryptophan metabolites
- (2018) J. J. Galligan NEUROGASTROENTEROLOGY AND MOTILITY
- Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation
- (2018) Allison M. Garrison et al. PSYCHONEUROENDOCRINOLOGY
- Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities
- (2018) Jae Eun Cheong et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
- (2018) Asha Nayak-Kapoor et al. Journal for ImmunoTherapy of Cancer
- Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome
- (2018) Jane M. Natividad et al. Cell Metabolism
- Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
- (2018) Tara C. Mitchell et al. JOURNAL OF CLINICAL ONCOLOGY
- Epacadostat plus nivolumab for advanced melanoma: Updated phase 2 results of the ECHO-204 study.
- (2018) Adil Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of kynurenine aminotransferase II attenuates hippocampus-dependent memory deficit in adult rats treated prenatally with kynurenine
- (2018) Ana Pocivavsek et al. HIPPOCAMPUS
- A Phase 2, Randomized Dose-Finding Study of Tapinarof (GSK2894512 Cream) for the Treatment of Plaque Psoriasis
- (2018) Kevin Robbins et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- De novo NAD+ synthesis enhances mitochondrial function and improves health
- (2018) Elena Katsyuba et al. NATURE
- A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer
- (2017) Rebecca Kristeleit et al. GYNECOLOGIC ONCOLOGY
- Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans
- (2017) Susan H. Smith et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate
- (2017) Stefano Crosignani et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS
- (2017) Tjalf Ziemssen et al. Journal of Neuroinflammation
- Melatonin's role as a co-adjuvant treatment in colonic diseases: A review
- (2017) Eduardo Esteban-Zubero et al. LIFE SCIENCES
- Feedback control of AHR signalling regulates intestinal immunity
- (2017) Chris Schiering et al. NATURE
- L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences
- (2017) Hidetsugu Fujigaki et al. NEUROPHARMACOLOGY
- Involvement of the kynurenine pathway in the pathogenesis of Parkinson’s disease
- (2017) Chai K. Lim et al. PROGRESS IN NEUROBIOLOGY
- Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
- (2017) Eric Plitman et al. SCHIZOPHRENIA BULLETIN
- Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase
- (2017) Jonathan P. Hutchinson et al. Nature Communications
- Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1
- (2017) Ariel Lewis-Ballester et al. Nature Communications
- Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
- (2017) Paul W. O’Toole et al. Nature Microbiology
- The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease
- (2016) Vahri Beaumont et al. EXPERIMENTAL NEUROLOGY
- The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases
- (2016) Jamie L. Harden et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis
- (2016) Damian J Mole et al. NATURE MEDICINE
- CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
- (2016) Bruno Lamas et al. NATURE MEDICINE
- Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model
- (2016) Ewelina Rojewska et al. NEUROPHARMACOLOGY
- Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor
- (2016) Joel Kaye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase I study of indoximod in patients with advanced malignancies
- (2016) Hatem H. Soliman et al. Oncotarget
- An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation
- (2016) L Brundin et al. Translational Psychiatry
- Blocking peripheral serotonin synthesis by telotristat etiprate (LX1032/LX1606) reduces severity of both chemical- and infection-induced intestinal inflammation
- (2015) Janice J. Kim et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Altered kynurenine pathway metabolism in autism: Implication for immune-induced glutamatergic activity
- (2015) Chai K. Lim et al. Autism Research
- Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder
- (2015) Jonathan Savitz et al. BRAIN BEHAVIOR AND IMMUNITY
- Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
- (2015) Jessica M. Yano et al. CELL
- Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells
- (2015) Christopher S. Reigstad et al. FASEB JOURNAL
- Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease
- (2015) Leticia M. Toledo-Sherman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tranilast: A review of its therapeutic applications
- (2015) Sara Darakhshan et al. PHARMACOLOGICAL RESEARCH
- Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia
- (2015) Francesco Fazio et al. Scientific Reports
- A phase II study of laquinimod in Crohn's disease
- (2014) Geert D'Haens et al. GUT
- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
- (2014) T. L. Vollmer et al. JOURNAL OF NEUROLOGY
- Reduction of Brain Kynurenic Acid Improves Cognitive Function
- (2014) R. Kozak et al. JOURNAL OF NEUROSCIENCE
- The Endogenous Tryptophan Metabolite and NAD+ Precursor Quinolinic Acid Confers Resistance of Gliomas to Oxidative Stress
- (2013) F. Sahm et al. CANCER RESEARCH
- Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
- (2012) L. Pilotte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia
- (2012) Amy B. Dounay et al. ACS Medicinal Chemistry Letters
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- Crystal Structure-Based Selective Targeting of the Pyridoxal 5′-Phosphate Dependent Enzyme Kynurenine Aminotransferase II for Cognitive Enhancement
- (2010) Franca Rossi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells
- (2010) Anthony E. Boitano et al. SCIENCE
- Sequence Variants in Kynurenine Aminotransferase II (KAT II) Orthologs Determine Different Potencies of the InhibitorS-ESBA
- (2008) Roberto Pellicciari et al. ChemMedChem
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More